课题基金 / 基金详情

Predictive and prognostic impacts of quality of life measurements and biomarker discovery in chemotherapy treated advanced pancreatic cancer patients in Northern Alberta

Predictive and prognostic impacts of quality of life measurements and biomarker discovery in chemotherapy treated advanced pancreatic cancer patients in Northern Alberta
生活质量测量和生物标志物发现对艾伯塔省北部接受化疗的晚期胰腺癌患者的预测和预后影响
批准号:
272936
负责人:
Kim Christina
金额:
$2.0万
依托单位:
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-10-01 至 2013-10-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
胰腺癌是一种非常致命的癌症。食欲不振、体重减轻、乏力和腹痛等症状非常模糊。因此,大约80%被诊断患有胰腺癌的人都有广泛的、不治之症。
英文摘要
Pancreas cancer is a very lethal cancer. The symptoms, such as a lack of appetite, weight loss, fatigue and abdominal pain, are very vague. Consequently, approximately 80% of people diagnosed with pancreas cancer have widespread and incurable disease at
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金